Dawn Health Secures €11.5 Million to Expand Digital Health Platform

Dawn Health has secured €11.5 million in funding from existing investors, including Chr. Augustinus Fabrikker, the Export and Investment Fund of Denmark (EIFO), and Trifork, announced in a press release. This investment aims to enhance the company's platform and product suite, which are designed to support global pharmaceutical companies through a SaaS model.

Since 2021, Dawn Health has focused on developing a platform tailored for the pharmaceutical industry, which has been adopted by major companies such as Merck and Novartis. The platform is utilized in areas like oncology, multiple sclerosis, and rare pediatric conditions, aiding patients in managing treatments and maintaining communication with healthcare providers.

The Dawn Platform leverages advanced AI capabilities, data analytics, and clinical integrations to improve patient outcomes and support pharma companies. This funding will allow Dawn Health to expand its market reach and continue investing in its product offerings, reinforcing its position as a trusted partner in the digital health sector.